AstraZeneca (LSE:AZN) Short-Term Capital Lease Obligation : £221 Mil (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is AstraZeneca Short-Term Capital Lease Obligation?

AstraZeneca's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was £221 Mil.

AstraZeneca's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (£190 Mil) to Dec. 2023 (£214 Mil) and increased from Dec. 2023 (£214 Mil) to Mar. 2024 (£221 Mil).

AstraZeneca's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (£175 Mil) to Dec. 2022 (£187 Mil) and increased from Dec. 2022 (£187 Mil) to Dec. 2023 (£214 Mil).

AstraZeneca Short-Term Capital Lease Obligation Historical Data

The historical data trend for AstraZeneca's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Short-Term Capital Lease Obligation Chart

AstraZeneca Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

143.44

142.85

175.22

187.19

214.09

AstraZeneca Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															191.17	182.95	189.88	214.09	221.15

AstraZeneca Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

AstraZeneca Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca (LSE:AZN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (LSE:AZN) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:USA AZN:Sweden AZNN:Mexico AZNl:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.